ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 328130 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 328130; 2) Community: the network communities that were significantly associated with the response to NSC 328130; 3) Molecule: the relationships between components within communities and NSC 328130; 4) MDR: the compounds that were significantly associated with the NSC 328130.

NSC Compound Enrichment Correlation
NSC 746540 Null 0.0414190425892871 0.373735
NSC 751152 3-(6/7-trifluoro-3-methyl-1,4-dioxy-quinoxaline-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone 0.0414190425892871 0.25850451
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0414190425892871 0.12780442
NSC 763703 (Z)-6-chloro-3-((2-(4-methoxyphenyl)-3H-benzo[d]imidazol-5-yl)methylene)indolin-2-one 0.0414190425892871 0.11806852
NSC 87222 ACTINOMYCIN C3 0.0414190425892871 0.17198569
NSC 163062 TRIPTOLIDE 0.0421163101172308 0.21514693
NSC 23936 Null 0.0421163101172308 0.61460922
NSC 266047 1,2-Cyclohexanediamine, platinum complex, (1R-trans)- (9CI) 0.0421163101172308 0.28631751
NSC 333054 Adriamycin, tetrahydropyranyl 0.0421163101172308 0.21436272
NSC 373355 Saframycin R 0.0421163101172308 0.10161442
Total:86  Current:78    [First] [Prev] [Next] [Last]